An enediyne-energized single-domain antibody-containing fusion protein shows potent antitumor activity-Reference-Cited by-同舟云学术

An enediyne-energized single-domain antibody-containing fusion protein shows potent antitumor activity

Published:2007-02 Issue:2 Volume:18 Page:127-137
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Miao Qing-fang,Liu Xiao-yun,Shang Bo-yang,Ouyang Zhi-gang,Zhen Yong-su

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference46 articles.

1. Monoclonal antibody therapy of cancer;Adams;Nat Biotechnol,2005

2. Targeting of bivalent anti-ErbB2 diabody antibody fragments to tumor cells is independent of the intrinsic antibody affinity;Nielsen;Cancer Res,2000

3. Engineered antibody fragments and the rise of single domains;Holliger;Nat Biotechnol,2005

4. Binding activities of a repertoire of single immunoglobulin variable domains secreted from Escherichia coli;Ward;Nature,1989

5. Efficient tumor targeting by single-domain antibody fragments of camels;Cortez-Retamozo;Int J Cancer,2002

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An albumin-binding lidamycin prodrug for efficient targeted cancer therapy;Journal of Drug Delivery Science and Technology;2024-01

2. Challenges and opportunities to develop enediyne natural products as payloads for antibody-drug conjugates;Antibody Therapeutics;2021-01-01

3. A novel anti-p21Ras scFv antibody reacting specifically with human tumour cell lines and primary tumour tissues;BMC Cancer;2016-02-20

4. A Gelatinases-targeting scFv-based Fusion Protein Shows Enhanced Antitumour Activity with Endostar against Hepatoma;Basic & Clinical Pharmacology & Toxicology;2015-02-20

5. Tuftsin-based, EGFR-targeting fusion protein and its enediyne-energized analog show high antitumor efficacy associated with CD47 down-regulation;Cancer Immunology, Immunotherapy;2014-08-28